Immunological markers that correlate with protection immunity against tularemia infection. 2014

Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
State Research Center for Applied Microbiology and Biotechnology, Moscow, Obolensk, Russia, 142279, firstova@obolensk.org.

An efficient immune response to tularemia is dependent on a strong cell-mediated component. We tried to identify markers of cellular immune responses that indicate a vaccine efficacy against tularemia. BALB/c mice were immunized with mutant F. tularensis 15∆23A and/or F. tularensis 15 NIIEG strains and then were challenged i.n. with F. tularensis Schu. We compared the influence of F. tularensis antigens (tularinum) in vitro on production of IL-1, IL-5, IL-6, IL-17, IFN-γ, and TNF-α by splenocytes obtained from intact mice and mice immunized with mutant F. tularensis 15∆23A and/or F. tularensis 15 NIIEG strains. We also compared expression of CD28, CD154, TLR-2, and CD69 markers on CD4 and CD8 T-cells after activation with tularinum in vitro. We found that tularinum-induced CD4(+) T-cells increased TNF-α and IFN-γ synthesis and expression of CD69 only in group mice with high degree of post immunization protection against F. tularensis Schu challenge. Estimation of CD69 expression on CD3(+)CD4(+) cells and IFN-γ, TNF-α synthesis by CD4(+) T-lymphocytes could be useful for determination protect ability of antitularemia immunity.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005604 Francisella tularensis The etiologic agent of TULAREMIA in man and other warm-blooded animals. Bacterium tularense,Brucella tularensis,Francisella tularense,Pasteurella tularensis
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial

Related Publications

Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
January 2017, PloS one,
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
June 2009, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
January 2006, Critical reviews in immunology,
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
September 2019, Vaccines,
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
January 2018, Frontiers in cellular and infection microbiology,
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
February 1962, The Journal of experimental medicine,
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
April 1984, Fel'dsher i akusherka,
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
March 2023, medRxiv : the preprint server for health sciences,
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
May 2021, Lancet (London, England),
Victoria V Firstova, and Alexander N Mokrievich, and Vitalii M Pavlov, and Aleksey A Gorbatov, and Tatiana I Kombarova, and Sergey F Biketov, and Ivan A Dyatlov
May 2022, Der Internist,
Copied contents to your clipboard!